Rhino Therapeutics Limited is an active company incorporated on 19 January 2023 with the registered office located in Cheltenham, Gloucestershire. Rhino Therapeutics Limited was registered 2 years 9 months ago.
Total exemption full accounts made up to 31 March 2025
Submitted on 30 Jun 2025
Confirmation statement made on 18 January 2025 with updates
Submitted on 20 Jan 2025
Total exemption full accounts made up to 31 March 2024
Submitted on 3 Jul 2024
Confirmation statement made on 18 January 2024 with updates
Submitted on 18 Jan 2024
Current accounting period extended from 31 January 2024 to 31 March 2024
Submitted on 18 Dec 2023
Appointment of Dr Andrew William Mulvaney as a director on 27 July 2023
Submitted on 2 Aug 2023
Registered office address changed from 4th Floor St. James Square Cheltenham Gloucestershire GL50 3PR England to Fourth Floor St James House St James' Square Cheltenham GL50 3PR on 28 July 2023
Submitted on 28 Jul 2023
Registered office address changed from 7B Back Lane Wymondham NR18 0QB England to 4th Floor St. James Square Cheltenham Gloucestershire GL50 3PR on 26 July 2023
Submitted on 26 Jul 2023
Notification of a person with significant control statement
Submitted on 18 Jul 2023
Cessation of Graham Michael Wynne as a person with significant control on 18 July 2023